Elevated tumor markers for monitoring tumor response to immunotherapy - eClinicalMedicine
Prognostic and Predictive Markers for the New Immunotherapies
Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy | Nature Communications
Interpretable systems biomarkers predict response to immune-checkpoint inhibitors - ScienceDirect
Cancer immunotherapy: it's time to better predict patients' response | British Journal of Cancer
Cancer Immunotherapy Biomarker… | College of American Pathologists
Frontiers | Predictive Biomarkers of Immune Checkpoint Inhibitors-Related Toxicities
Discordance of immunotherapy response predictive biomarkers between primary lesions and paired metastases in tumours: A systematic review and meta-analysis - eBioMedicine
A novel immune-related gene signature predicting survival in sarcoma patients: Molecular Therapy - Oncolytics
Frontiers | Biomarkers in Immunotherapy-Based Precision Treatments of Digestive System Tumors
Prediction of biomarkers and therapeutic combinations for anti-PD-1 immunotherapy using the global gene network association | Nature Communications
PD-1-high TILs: a predictive biomarker for ICB in lung cancer
Frontiers | FDA-Approved and Emerging Next Generation Predictive Biomarkers for Immune Checkpoint Inhibitors in Cancer Patients
Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy | Molecular Cancer | Full Text
Predictive biomarkers for checkpoint inhibitor-based immunotherapy - The Lancet Oncology
Biomarkers for precision immunotherapy in the metastatic setting: hope or reality? - ecancer
Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy | Molecular Cancer | Full Text
PDF) Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
Cancers | Free Full-Text | Immunotherapy Predictive Molecular Markers in Advanced Gastroesophageal Cancer: MSI and Beyond
Biomarkers of response to PD-1 pathway blockade | British Journal of Cancer
Frontiers | From rough to precise: PD-L1 evaluation for predicting the efficacy of PD-1/PD-L1 blockades
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors | Biomarker Research | Full Text
Biomarkers in Precision Cancer Immunotherapy: Promise and Challenges | American Society of Clinical Oncology Educational Book
Frontiers | Progress Toward Identifying Exact Proxies for Predicting Response to Immunotherapies
Predictive Biomarkers for Immunotherapy Response Beyond PD-1/PD-L1
